Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Pacific Biosciences of California Inc |
6/02 | 1,820 USD
+6,12% |
+6,12% |
|
Pacira BioSciences Inc |
6/02 | 21,000 USD
+3,14% |
+3,14% |
|
PainReform Ltd |
6/02 | 2,960 USD
+389,74% |
+389,74% |
|
Passage Bio Inc |
6/02 | 9,510 USD
+4,39% |
+4,39% |
|
PAVmed Inc |
6/02 | 10,800 USD
+2,08% |
+2,08% |
|
PDS Biotechnology Corporation |
6/02 | 0,715 USD
+3,59% |
+3,59% |
|
Penumbra Inc |
6/02 | 341,020 USD
-0,29% |
-0,29% |
Perimeter Medical Imaging AI Inc |
6/02 | 0,255 CAD
+2,00% |
+2,00% |
|
Perrigo Company plc |
6/02 | 14,640 USD
+2,59% |
+2,59% |
|
Personalis Inc |
6/02 | 8,055 USD
+8,63% |
+8,63% |
|
Perspective Therapeutics Inc |
6/02 | 4,710 USD
+1,73% |
+1,73% |
|
PetVivo Holdings Inc |
6/02 | 0,860 USD
+1,18% |
+1,18% |
|
Pfizer |
6/02 | 27,220 USD
+2,76% |
+2,76% |
Pharming Group N.V. |
6/02 | 1,366 EUR
-2,43% |
-2,43% |
|
Pharming Group N.V. |
6/02 | 16,090 USD
+0,31% |
+0,31% |
|
Phathom Pharmaceuticals Inc |
6/02 | 12,580 USD
+1,37% |
+1,37% |
|
Phibro Animal Health Corp. |
6/02 | 53,070 USD
+6,14% |
+6,14% |
|
Philips |
6/02 | 24,790 EUR
+0,85% |
+0,85% |
|
Phio Pharmaceuticals Corp |
6/02 | 0,920 USD
+7,39% |
+7,39% |
Plant Advanced Technologies Pat |
6/02 | 8,400 EUR
+0,48% |
+0,48% |
|
Pliant Therapeutics Inc |
6/02 | 1,140 USD
+4,59% |
+4,59% |
|
Plus Therapeutics Inc |
6/02 | 0,260 USD
+11,16% |
+11,16% |
Polarean Imaging Plc |
22/12 | 0,080 GBX
-20,00% |
-20,00% |
|
Polypid Ltd |
6/02 | 4,520 USD
+3,91% |
+3,91% |
|
Poxel |
6/02 | 0,307 EUR
-5,40% |
-5,40% |
|
Praxis Precision Medicines Inc |
6/02 | 319,570 USD
+4,56% |
+4,56% |
|
Precigen Inc |
6/02 | 4,290 USD
+1,18% |
+1,18% |
|
Precipio Inc |
6/02 | 20,060 USD
-1,52% |
-1,52% |
|
Precision Biosciences Inc |
6/02 | 3,800 USD
+6,44% |
+6,44% |
|
Predictive Oncology Inc |
6/02 | 2,300 USD
+0,88% |
+0,88% |
|
Prelude Therapeutics Inc |
6/02 | 2,170 USD
+7,43% |
+7,43% |
|
Prestige Consumer Healthcare Inc |
6/02 | 66,330 USD
+1,19% |
+1,19% |
|
Profound Medical Corp |
6/02 | 6,490 USD
+2,69% |
+2,69% |
|
ProMIS Neurosciences Inc. |
6/02 | 12,730 USD
-2,82% |
-2,82% |
|
ProPhase Labs Inc |
6/02 | 0,150 USD
+7,14% |
+7,14% |
|
ProQR Therapeutics N.V |
6/02 | 1,500 USD
+2,74% |
+2,74% |
|
Protagonist Therapeutics Inc |
6/02 | 84,490 USD
+4,74% |
+4,74% |
|
Protara Therapeutics Inc |
6/02 | 6,650 USD
+2,31% |
+2,31% |
|
Proteome Sciences plc |
6/02 | 1,770 GBX
+0,85% |
+0,85% |
|
Prothena Corporation plc |
6/02 | 8,910 USD
+6,71% |
+6,71% |
|
PTC Therapeutics Inc |
6/02 | 74,680 USD
+3,21% |
+3,21% |
|
Pulmatrix Inc |
6/02 | 2,480 USD
-0,40% |
-0,40% |
|
Pulmonx Corp |
6/02 | 1,500 USD
+3,45% |
+3,45% |
|
Pulse Biosciences Inc |
6/02 | 20,750 USD
+51,57% |
+51,57% |
|
Puma Biotechnology Inc |
6/02 | 6,940 USD
+2,21% |
+2,21% |
|
PureTech Health Plc |
6/02 | 18,090 USD
-2,22% |
-2,22% |
|
PureTech Health Plc |
6/02 | 126,600 GBX
-1,25% |
-1,25% |